Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries.

[1]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.

[2]  K. Schenck-Gustafsson,et al.  Sex differences in cardiovascular disease – Impact on care and outcomes , 2017, Frontiers in Neuroendocrinology.

[3]  Joshua Schulman-Marcus,et al.  Sex differences in nonobstructive coronary artery disease: Recent insights and substantial knowledge gaps. , 2017, Trends in cardiovascular medicine.

[4]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[5]  F. Crea,et al.  The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. , 2016, European heart journal.

[6]  F. Crea,et al.  International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.

[7]  K. Gould,et al.  Imaging Microvascular Dysfunction and Mechanisms for Female-Male Differences in CAD. , 2016, JACC. Cardiovascular imaging.

[8]  Yuta Sudo,et al.  Moderate vasomotor response to acetylcholine provocation test as an indicator of long-term prognosis , 2016, Heart and Vessels.

[9]  J. Kastrup,et al.  Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study , 2016, Journal of the American Heart Association.

[10]  Yasuhiro Honda,et al.  Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.

[11]  R Jay Widmer,et al.  Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.

[12]  M. Arstall,et al.  Clinical determinants of acetylcholine-induced coronary artery spasm in Australian patients. , 2015, International journal of cardiology.

[13]  F. Crea,et al.  Sex differences in mechanisms, presentation and management of ischaemic heart disease. , 2015, Atherosclerosis.

[14]  S. Sueda,et al.  Overview of the Acetylcholine Spasm Provocation Test , 2015, Clinical cardiology.

[15]  T. Miyoshi,et al.  Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test , 2016, Heart and Vessels.

[16]  T. Miyoshi,et al.  Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm , 2016, Heart and Vessels.

[17]  T. Miyoshi,et al.  Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine , 2015, Heart and Vessels.

[18]  O. Rimoldi,et al.  Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.

[19]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[20]  S. Hokimoto,et al.  Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 Years , 2013, Journal of the American Heart Association.

[21]  A. Stuck,et al.  Invasive findings in patients with angina equivalent symptoms but no coronary artery disease; results from the heart quest cohort study. , 2013, International journal of cardiology.

[22]  U. Sechtem,et al.  Gender aspects in patients with angina and unobstructed coronary arteries , 2013, Clinical Research in Cardiology Supplements.

[23]  Y. Kihara,et al.  Evaluation of coronary microvascular function in patients with vasospastic angina. , 2013, World journal of cardiology.

[24]  H. Shimokawa,et al.  Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. , 2013, European Heart Journal.

[25]  E. Picano,et al.  Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. , 2012, JACC. Cardiovascular imaging.

[26]  L. Shaw,et al.  Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. , 2012, JACC. Cardiovascular interventions.

[27]  J. Kaski,et al.  Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X) , 2012, Clinical Research in Cardiology.

[28]  Erik Jørgensen,et al.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.

[29]  Carl J Pepine,et al.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.

[30]  L. Lerman,et al.  Lack of Correlation Between Noninvasive Stress Tests and Invasive Coronary Vasomotor Dysfunction in Patients With Nonobstructive Coronary Artery Disease , 2009, Circulation. Cardiovascular interventions.

[31]  C. Pepine Provoked coronary spasm and acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[32]  Y. Honda,et al.  Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: a novel predictor of prognosis after acute myocardial infarction. , 2008, Journal of the American College of Cardiology.

[33]  S. Reis,et al.  Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) , 2007, Clinical cardiology.

[34]  A. Macías,et al.  Ergonovine test in angina with normal coronary arteries. Is it worth doing it? , 2006, International journal of cardiology.

[35]  Carl J Pepine,et al.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.

[36]  C Noel Bairey Merz,et al.  Angina with "normal" coronary arteries. , 2005 .

[37]  H. Fukuda,et al.  Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations , 2004, Coronary artery disease.

[38]  J. Kaski Overview of gender aspects of cardiac syndrome X. , 2002, Cardiovascular research.

[39]  J. Tanguay,et al.  Complications of cardiac catheterization in the current era: A single‐center experience , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  S. Kimmel,et al.  Contemporary trends in coronary intervention: A report from the registry of the Society for Cardiac Angiography and Interventions , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  Y. Yamada,et al.  Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm. , 1999, Journal of cardiology.

[42]  N. Ochi,et al.  Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. , 1999, The American journal of cardiology.

[43]  T. Nakamura,et al.  Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. , 1992, American Heart Journal.

[44]  W. Edwards,et al.  Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. , 1988, Mayo Clinic proceedings.

[45]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[46]  L. Hagerup,et al.  Relationship between heart weight and the cross sectional area of the coronary ostia. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.